Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41
Reported: June 24, 2020 Initiated: May 28, 2020 #D-1324-2020
Product Description
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41
Reason for Recall
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Details
- Recalling Firm
- Glaxosmithkline Consumer Healthcare Holdings
- Units Affected
- 629,796 bottles
- Distribution
- U.S.A. Nationwide
- Location
- Warren, NJ
Frequently Asked Questions
What product was recalled? ▼
Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41. Recalled by Glaxosmithkline Consumer Healthcare Holdings. Units affected: 629,796 bottles.
Why was this product recalled? ▼
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on June 24, 2020. Severity: Moderate. Recall number: D-1324-2020.
Related Recalls
NHTSA Critical
LEXUS 2025: POWER TRAIN:AUTOMATIC TRANSMISSION
LEXUS · 2026-02-18
NHTSA Critical
CADILLAC,CHEVROLET,GMC 2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CADILLAC,CHEVROLET,GMC · 2026-02-13
NHTSA Critical
CHEVROLET,GMC 2020-2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CHEVROLET,GMC · 2026-02-12
NHTSA Critical
CADILLAC 2024: BACK OVER PREVENTION:SOFTWARE
CADILLAC · 2026-02-12
NHTSA Critical
NISSAN 2024-2025: FUEL SYSTEM, GASOLINE:FUEL INJECTION SYSTEM:THROTTLEBODY/MANIFOLD
NISSAN · 2026-02-12